v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ 53,759 $ (13,802)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 13,629 12,177
Amortization of intangibles 6,209 4,919
Non-cash stock-based compensation 7,159 4,821
Non-cash operating lease expense 3,750 4,113
Amortization of convertible debt discount 1,247 864
Amortization of debt issue costs 88 112
Loss on extinguishment of debt 0 1,400
Loss on termination of cash flow hedge 0 3,506
Gain on investment in and loan receivable from non-consolidated affiliate, net (91,510) 0
Interest receivable on loan receivable from non-consolidated affiliate (391) 0
Write-off of COVID-19 PCR testing inventory and equipment 6,061 0
Other non-cash items 790 263
Changes in assets and liabilities, net    
Accounts receivable, net 1,155 6,498
Inventories 3,645 (6,688)
Prepaid lease asset (4,730) (6,084)
Prepaid and other assets (4,681) (5,975)
Accounts payable, accrued and other liabilities 4,640 (11,175)
Net cash provided by (used in) operating activities 820 (5,051)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of marketable securities (162,769) 0
Proceeds from sales and maturities of marketable securities 26,253 0
Purchases of property and equipment (37,178) (9,734)
Business acquisitions, net of cash acquired (419,404) (37,000)
Loan receivable from non-consolidated affiliate (15,000) 0
Investment in non-consolidated affiliate 0 (13,137)
Net cash used in investing activities (608,098) (59,871)
CASH FLOWS FROM FINANCING ACTIVITIES    
Repayment of equipment financing obligations (1,892) (3,059)
Repayment of term loan 0 (97,540)
Cash flow hedge termination 0 (3,317)
Issuance of common stock, net 8,045 5,469
Proceeds from issuance of convertible debt, net of issuance costs 334,410 194,376
Premiums paid for capped call confirmations (29,291) 0
Proceeds from equity offerings, net of issuance costs 418,273 127,288
Net cash provided by financing activities 729,545 223,217
Net change in cash, cash equivalents and restricted cash 122,267 158,295
Cash, cash equivalents and restricted cash, beginning of period 250,632 173,016
Cash, cash equivalents and restricted cash, end of period 372,899 331,311
Cash and cash equivalents 368,796 295,281
Restricted cash 4,103 36,030
Supplemental disclosure of cash flow information:    
Interest paid 1,329 1,562
Income taxes paid, net 114 89
Supplemental disclosure of non-cash investing and financing information:    
Fair value of common stock issued to fund business acquisition 29,174 0
Equity offering issuance costs included in accrued expenses 10,137 0
Equipment acquired under financing obligations 0 428
Property and equipment included in accounts payable $ 3,822 $ 2,487

Source